# NBO Pharma Inc. — Form D

NBO Pharma Inc. of BEDFORD, NY, a company, filed a Form D exempt-offering notice with the SEC on 2026-01-22. The offering totals $7.6M, of which $7.6M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2026-01-22
- Form: D
- Accession: 0002103906-26-000001
- Industry: Pharmaceuticals
- Exemptions: 06c
- Total offering: $7.6M
- Amount sold: $7.6M
- Minimum investment: $10K
- Investors: 93
- Date of first sale: 2025-06-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-570878

## Issuer

- Name: NBO Pharma Inc.
- CIK: 0002103906
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 64 QUARRY LANE, BEDFORD, NY, 10506
- Phone: 914-645-1130

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Colin David Foster | Director | Woodbridge, CT |
| Robert David Friedman | Director | Teaneck, NJ |
| Bard David Geesaman | Director | Marlboro, MA |
| Fredric David Price | Director | Bedford, NY |
| Fredric David Price | Executive Officer | Bedford, NY |

## More

- [CIK 2103906 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2103906&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002103906-26-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.